Planning the joint development of companion diagnostics

Planning the joint development of companion diagnostics

HomeU.S. Food and Drug AdministrationPlanning the joint development of companion diagnostics
Planning the joint development of companion diagnostics
ChannelPublish DateThumbnail & View CountDownload Video
Channel AvatarPublish Date not found Thumbnail
0 Views
Donna Roscoe, PhD, from the Department of Molecular Genetics and Pathology
The Office of In Vitro Diagnostics and Radiological Health at CDRH discusses points to consider when planning companion diagnostics, including the use of investigational tests, the impact of study design on indication, common pitfalls, and how to obtain regulatory feedback.
For more information, visit: https://www.fda.gov/drugs/news-events-human-drugs/oncology-therapy-development-workshop-pivotal-steps-and-avoiding-pitfalls-start-ups-03302021
——————–
FDA CDER's Small Business and Industry Assistance (SBIA) provides training and assistance in understanding the regulatory aspects of human drugs and clinical research.

Upcoming trainings – https://www.fda.gov/cdersbia
SBIA Listserv – https://public.govdelivery.com/accounts/USFDA/subscriber/new?topic_id=USFDA_352
SBIA 2021 Playlist – https://youtube.com/playlist?list=PLey4Qe-UxcxYS1MaTusSgyifQDqdeepyD
SBIA LinkedIn: https://www.linkedin.com/showcase/cder-small-business-and-industry-assistance
SBIA Training Resources – https://www.fda.gov/cdersbialearn
Twitter – https://twitter.com/FDA_Drug_Info
Email – [email protected]
Telephone – (301) 796-6707 I (866) 405-5367

Please take the opportunity to connect with your friends and family and share this video with them if you find it useful.